ICU Medical (ICUI) Upgraded at BidaskClub

ICU Medical (NASDAQ:ICUI) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a report released on Friday, BidAskClub reports.

A number of other equities research analysts have also weighed in on the stock. Raymond James lowered their price target on shares of ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a report on Friday, March 1st. TheStreet lowered shares of ICU Medical from a “b-” rating to a “c+” rating in a report on Tuesday, March 19th. Finally, Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $262.00 price target for the company in a report on Thursday, March 7th. Three research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company’s stock. ICU Medical presently has an average rating of “Buy” and a consensus target price of $281.00.

ICUI opened at $225.66 on Friday. The firm has a market cap of $4.65 billion, a P/E ratio of 29.27 and a beta of 0.69. ICU Medical has a twelve month low of $210.94 and a twelve month high of $321.70.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.96 by $0.39. The business had revenue of $330.93 million during the quarter, compared to analyst estimates of $318.97 million. ICU Medical had a net margin of 4.04% and a return on equity of 13.70%. The business’s revenue was down 11.0% on a year-over-year basis. During the same period last year, the business earned $2.26 EPS. Equities analysts anticipate that ICU Medical will post 8.55 earnings per share for the current year.

In other ICU Medical news, Director Robert S. Swinney sold 229 shares of the firm’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of $231.43, for a total transaction of $52,997.47. Following the completion of the transaction, the director now directly owns 18,076 shares of the company’s stock, valued at approximately $4,183,328.68. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Virginia Ruth Sanzone sold 5,277 shares of the firm’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $232.31, for a total transaction of $1,225,899.87. Following the transaction, the vice president now directly owns 13,167 shares of the company’s stock, valued at $3,058,825.77. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 12,318 shares of company stock valued at $2,839,576. Company insiders own 11.40% of the company’s stock.

A number of hedge funds have recently made changes to their positions in ICUI. Advisory Services Network LLC grew its holdings in ICU Medical by 475.0% during the 4th quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 95 shares in the last quarter. We Are One Seven LLC acquired a new position in ICU Medical during the 4th quarter worth $32,000. Berman Capital Advisors LLC acquired a new position in ICU Medical during the 4th quarter worth $33,000. CX Institutional acquired a new position in ICU Medical during the 1st quarter worth $34,000. Finally, Rockefeller Capital Management L.P. acquired a new position in ICU Medical during the 1st quarter worth $35,000. 89.62% of the stock is owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Recommended Story: Trading based on a resistance level

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.